Peritoneal infections

Advances in Renal Replacement Therapy

Volumn 7, Issue 4, 2000, Pages 280-288

  Piraino, B ^a  

^a A9152 Scaife Hall ^*  (United States)

Author keywords

Exit site infections; Peritoneal dialysis; Peritonitis; S aureus

Indexed keywords

CEFAZOLIN; CEFTAZIDIME; VANCOMYCIN;

ANTIBIOTIC THERAPY; CATHETER; DISEASE CONTROL; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PATIENT CARE; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; TREATMENT INDICATION;

EID: 0033778576     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: 10.1053/jarr.2000.18035     Document Type: Article

References (59)

1. Peritonitis during continuous ambulatory peritoneal dialysis
2. Peritonitis influences mortality in peritoneal dialysis patients
3. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes
4. Hospitalization in peritoneal dialysis patients
5. Risk factors for peritonitis in long-term peritoneal dialysis: The network 9 peritonitis and catheter survival studies
6. Outcomes of single organism peritonitis in peritoneal dialysis: Gram negative versus gram posities in the The Network 9 Peritonitis Study
7. A comparative analysis on the incidence of peritonitis and exit site infection in CAPD and automated peritoneal dialysis
8. Pain due to Peritonitis
9. Peritoneal dialysis catheter exit site infections: Prevention, diagnosis, treatment, and future directions
10. Continuous ambulatory peritoneal dialysis catheter infections: Diagnosis and management
11. Natural history of exit site infection in patients on continuous ambulatory peritoneal dialysis
12. The clinical experience and natural course of peritoneal catheter exit site infection among continuous ambulatory peritoneal dialysis patients
13. Peritonitis associated with exit site and tunnel infections
14. Results of ultrasound-assisted diagnois of tunnel infections in continuous ambulatory peritoneal dialysis
15. Ultrasound as a tool in the diagnosis and management of exit-site infections in patients undergoing continuous ambulatory peritoneal dialysis
16. Frequent involvement of the internal cuff segment in CAPD peritonitis and exit site infection -An ultrasound study
17. New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography
18. Ultrasonography of the catheter tunnel in peritoneal dialysis patients: What are the indications?
19. Staphylococcus aureus CAPD-related infections are associated with nasal carriage
20. Natural history of Staphylococcus aureus nasal carriage and its relationship to exit site infection
21. New strate* gies to prevent Staphylococcus aureus infections in peritoneal dialysis patients
22. Impaired outcome of continuous ambulatory peritoneal dialysis in immunosuppressed patients
23. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin
24. Randomized Controlled trial of prophylactic rifampin for peritoneal dialysis related infections
25. Nasal mupirocin prevents Staphylococcus aureus exit site infection during peritoneal dialysis
26. Treatment of Staphylococcus aureus nasal carriers in Continuous ambulatory peritoneal dialysis with mupirocin: Long-term results
27. Decrease in Staphylococcus aureus exit site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site
28. Impaired initial cell reaction in CAPD-related peritonitis
29. Isolation of organisms in CAPD peritonitis: A comparison of two techniques
30. Surreptitious use of antimicrobial agents by CAPD patients
31. Culture negative CAPD Peritonitis: The Network 9 Study
32. Touch contamination of connection devices in peritoneal dialysis A quantitative microbiologic analysis
33. Acute treatment of constipation may lead to transmural migration of bacteria resulting in Gram negative, polymicrobial or fungal peritonitis
34. Risk factors for developing peritonitis caused by micro-organisms of enteral origin in peritoneal dialysis patients
35. Abdominal catastrophe: Visceral injury as a cause of peritonitis in patients treated by peritoneal dialysis
36. Bacterial peritonitis following endoscopic variceal sclerotherapy
37. Iatrogenic peritonitis: The need for prophylaxis
38. Peritonitis due to an intrauterine device in a patient on CAPD
39. Peritoneal Dialysis-related peritonitis treatment recommendations: 2000 Update
40. Emergence of vancomycin resistance in coagulase-negative staphylococci
41. Effect of aminoglycoside use on residucal renal function in peritoneal dialysis patients
42. Vancomycinresistant enterococci and emperical vancomycin for CAPD peritonitis
43. Rising incidence of methicillin resistant staphylococcal infections in PD patients
44. The need for a center-tailored treatment protocol for peritonitis
45. Pharmacokinetics of intermittent cefazolin and tobramycin in patients treated with automated peritoneal dialysis
46. Treatment in PD patients of peritonitis caused by Gram positive organ isms with single daily dose of antibiotics
47. Troughserum vancomycin levels predict the relapse of Gram positive peritonitis in peritoneal dialysis patients
48. Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: A doubleblind clinical trial
49. Tenckhoff catheter replacement or intraperitoneal urokinase: A randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis
50. Simultaneous removal and replacement of infected peritoneal dialysis catheters
51. Persistence of positive dialysate cultures after apparent cure of CAPD peritonitis
52. Streptococcal versus Staphylococcus epidermidis peritonitis in CAPD. A comparative study
53. Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci
54. Effectiveness of once-weekly vancomycin and once-daily gentamicin, intraperitoneally, for CAPD peritonitis
55. Polymicrobial peritonitis in patients on continuous peritoneal dialysis
56. Fungal Peritonitis in a large chronic peritoneal dialysis population: A report of 55 episodes
57. Optimal treatment and long-term outcome of tuberculous peritonitis complicating continuous ambulatory peritoneal dialysis
58. The peritonitis study group in Japan and Baxter Healthcare. A multicenter study of CAPD related peritonitis in Japan
59. A prospective randomized control study of oral nystatin rophylaxis for candida peritonitis complicating continuous ambulatory peritoneal dialysis